These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Some behavioral effects of 1,3-di-o-tolylguanidine, opipramol and sertraline, the sigma site ligands. Maj J, Rogóz Z, Skuza G. Pol J Pharmacol; 1996; 48(4):379-95. PubMed ID: 9112678 [Abstract] [Full Text] [Related]
8. Involvement of haloperidol-sensitive sigma-sites in antitussive effects. Kamei J, Iwamoto Y, Kawashima N, Hitosugi H, Misawa M, Kasuya Y. Eur J Pharmacol; 1992 Nov 24; 224(1):39-43. PubMed ID: 1451741 [Abstract] [Full Text] [Related]
10. The sigma receptor ligand 1,3-di(2-tolyl)guanidine is anticonvulsant in the rat prepiriform cortex. Roth JE, Franklin PH, Murray TF. Eur J Pharmacol; 1993 May 19; 236(2):327-31. PubMed ID: 8319759 [Abstract] [Full Text] [Related]
14. Relationship between modulation of the cerebellorubrospinal system in the in vitro turtle brain and changes in motor behavior in rats: effects of novel sigma ligands. Matsumoto RR, Bowen WD, de Costa BR, Houk JC. Brain Res Bull; 1999 Mar 15; 48(5):497-508. PubMed ID: 10372510 [Abstract] [Full Text] [Related]